With ground-breaking clinical success leading to FDA-approved products and with vibrant, exponentially growing research, lymphocyte engineering is the wave of the future.

The 2022 program is designed to spotlight the latest innovations in lymphocyte engineering from around the world and provide a discussion forum to help advance the field. Interested in speaking at ICLE 2022? Apply here!

Here is a sneak peek at what we will discuss in Munich:

Thursday 31 March

CAR T Cell Therapies in Hematological Malignancies – Stan Riddell, Fred Hutchinson Cancer Research Center, USA; Yuqin Song, Peking University Cancer Hospital, China; Chiara Bonini, San Raffaele University, Italy; Michal Besser, Tel Aviv University, Israel; Jennifer Brogdon, Novartis Institutes for Biomed.Research, Inc., USA

Friday 1 April

New Approaches in Lymphocyte Engineering I – Michel Sadelain, Memorial Sloan Kettering Cancer Center, USA; Tobias Feuchtinger, Ludwig-Maximilians-University, Germany; Gianpietro Dotti, University of North Carolina Lineberger Comprehensive Cancer Center, USA

Saturday 2 April

Non-Viral Vectors and Transposons – Shigeki Yagyu, Prefectural University of Medicine, Japan; Michael Hudecek, Hospital of the University of Würzburg, Germany

Review our program for more details and spot other sessions that may interest you.

By registering and joining the ICLE community you will:

• Participate in the only event that merges all the exciting breakthroughs under one conference – gene therapy, cell therapy, genome engineering, and immunotherapy.
• Gain access to quality networking with colleagues advancing related knowledge across diseases.
• Meet the thought leaders sharing invaluable insights on CAR-T Cell and other lymphocyte engineering therapies.
• Present your research, clinical findings, therapies, and pipeline to a focused international audience.
• Become part of the only community across industry and academia dedicated to lymphocyte engineering.

Haven’t secured your place yet? Now is the time to do so – savings end on 15 December 2021!

Take this opportunity to book your front-row seat to the leading lymphocyte engineering meeting for 2022 and enjoy multidisciplinary science, presented by world-renowned experts all whilst saving on your Conference ticket.

See you in Munich for a long-awaited meeting!